Published Date: 02 Mar 2023
Members of Congress are scrambling to test whether Bayh-Dole's "walk-in" provisions for patents on federally-funded discoveries could lower the cost of certain drugs in the United States.
Read Full NewsHome visits — once common and now resurging — flip the dynamic, as the clinician becomes a guest in the patient's home. Experts say as both learn more about each other than is possible in-office, trust can build.
Higher body fat percentage, rather than BMI, is associated with reduced sperm count and disrupted reproductive hormone levels in men.
Standard TKI doses are often too high for long-term care. Dr Mark Kris shares his strategy for smart dose reductions that protect patient outcomes.
Cure rates are climbing, and so is the complexity of getting there. Dr Yara Abdou takes a closer look at optimizing HER2+ early-stage breast cancer therapy.
Direct primary care is more than medicine. Dr Rajdeep Dhami shares what physicians should know before starting DPC, from operations and branding to boundaries and community.
1.
Belzutifan Combo Could be Second-Line Option in Advanced RCC
2.
Low PSA May Not Fully Predict Survival in Prostate Cancer
3.
T-DXd Reduces Residual Disease in Early Breast Cancer
4.
Advancing Health in Africa
5.
Antitumor mRNA-based vaccines show potential against gastric cancer metastasis
1.
Clinical Guidelines for Hematopoietic Stem Cell Niche Monitoring in Blood Disorders
2.
Beyond Symptoms: The Predictive Promise of Targeted Radionuclide Therapy in Palliative Oncology
3.
Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment
4.
Machine Learning in Hematology: Boosting Diagnostic Precision and Speed in Medical Practice
5.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
2.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
3.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
4.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
5.
Current Scenario of Cancer- Q&A Session to Close the Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation